Enrique Poradosu - 12 Jan 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Science & Business Off
Signature
/s/ Enrique Poradosu
Issuer symbol
NVCT
Transactions as of
12 Jan 2023
Net transactions value
$0
Form type
4
Filing time
13 Jan 2023, 16:05:12 UTC
Previous filing
16 May 2022
Next filing
28 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +115,000 +9.1% $0.000000 1,373,319 12 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026.
F2 Includes 48,399 shares of restricted stock and 175,000 restricted stock units.